KEGG T03090: 103071508

Lipotes vexillifer (Yangtze River dolphin): 103071508

Entry

103071508         CDS       T03090

Symbol

IL2

Name

(RefSeq) interleukin-2

K05429

interleukin 2

Organism

lve Lipotes vexillifer (Yangtze River dolphin)

Pathway

lve04060

Cytokine-cytokine receptor interaction

lve04061

Viral protein interaction with cytokine and cytokine receptor

lve04151

PI3K-Akt signaling pathway

lve04625

C-type lectin receptor signaling pathway

lve04630

JAK-STAT signaling pathway

lve04658

Th1 and Th2 cell differentiation

lve04659

Th17 cell differentiation

lve04660

T cell receptor signaling pathway

lve04672

Intestinal immune network for IgA production

lve04940

Type I diabetes mellitus

lve05135

Yersinia infection

lve05142

Chagas disease

lve05162

Measles

lve05166

Human T-cell leukemia virus 1 infection

lve05171

Coronavirus disease - COVID-19

lve05200

Pathways in cancer

lve05320

Autoimmune thyroid disease

lve05321

Inflammatory bowel disease

lve05330

Allograft rejection

lve05332

Graft-versus-host disease

Brite

KEGG Orthology (KO) [BR:lve00001]
09130 Environmental Information Processing
  09132 Signal transduction
   04630 JAK-STAT signaling pathway
    103071508 (IL2)
   04151 PI3K-Akt signaling pathway
    103071508 (IL2)
  09133 Signaling molecules and interaction
   04060 Cytokine-cytokine receptor interaction
    103071508 (IL2)
   04061 Viral protein interaction with cytokine and cytokine receptor
    103071508 (IL2)
09150 Organismal Systems
  09151 Immune system
   04625 C-type lectin receptor signaling pathway
    103071508 (IL2)
   04660 T cell receptor signaling pathway
    103071508 (IL2)
   04658 Th1 and Th2 cell differentiation
    103071508 (IL2)
   04659 Th17 cell differentiation
    103071508 (IL2)
   04672 Intestinal immune network for IgA production
    103071508 (IL2)
09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    103071508 (IL2)
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    103071508 (IL2)
   05171 Coronavirus disease - COVID-19
    103071508 (IL2)
   05162 Measles
    103071508 (IL2)
  09171 Infectious disease: bacterial
   05135 Yersinia infection
    103071508 (IL2)
  09174 Infectious disease: parasitic
   05142 Chagas disease
    103071508 (IL2)
  09163 Immune disease
   05320 Autoimmune thyroid disease
    103071508 (IL2)
   05321 Inflammatory bowel disease
    103071508 (IL2)
   05330 Allograft rejection
    103071508 (IL2)
   05332 Graft-versus-host disease
    103071508 (IL2)
  09167 Endocrine and metabolic disease
   04940 Type I diabetes mellitus
    103071508 (IL2)
09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04052 Cytokines and neuropeptides [BR:lve04052]
    103071508 (IL2)
   00536 Glycosaminoglycan binding proteins [BR:lve00536]
    103071508 (IL2)
Cytokines and neuropeptides [BR:lve04052]
Cytokines
  Interleukins
   103071508 (IL2)
Glycosaminoglycan binding proteins [BR:lve00536]
Heparan sulfate / Heparin
  Cytokines
   103071508 (IL2)

SSDB

Motif

Pfam:

IL2 CDK5RAP3

Other DBs

NCBI-GeneID:

103071508

NCBI-ProteinID:

XP_007464893

UniProt:

A0A340XUF4

LinkDB

Position

Unknown

AA seq 154 aa
MYKMQLLSCIALTLALVANGAPTSSSTENTKKQVQSLLQDLHLLLKEINNYKNLKLFRML
TFKFYMPKKATELKHLQCLAEELKPLEDVLNVAQSKTQNSIDIKDLMDNINRIVLTLKGS
ETRFRCEYDDETVTAVEFLNKWITFCQSIYSTMT

NT seq 465 nt +upstreamnt +downstreamnt
atgtacaagatgcaactcttgtcttgcattgcactaactcttgcacttgtggcaaacggt
gcacctacttcaagctctacagagaacacaaagaaacaagtgcagtcattgctgcaggat
ttacatttgcttttgaaggaaattaataattacaagaacctcaagctcttcaggatgctc
acatttaaattttacatgcccaagaaggctacagaattgaaacatcttcagtgtctagca
gaagaactcaaacctctggaggatgtgctaaatgttgctcaaagcaaaacccagaactcg
atagatatcaaagatttaatggacaatatcaacagaatagttttgacactaaagggatct
gaaacaagattcagatgtgaatatgatgatgagacagtaactgctgtagaatttctgaac
aaatggattaccttttgtcaaagcatctactcaacaatgacttga

DBGET integrated database retrieval system